Recent studies with human and mouse CMT models suggest that CMT1A might be “dysmyelination” disorder instead of demyelination, where myelination is delayed and hardly recovers to normal levels [57]. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease.